Status:
COMPLETED
Randomized, Open Investigation Evaluating the Efficacy of Nobel Biocare SFB and CFB Implants
Lead Sponsor:
Nobel Biocare
Conditions:
Partial Edentulism
Complete Edentulism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the survival rate, marginal bone resorption, soft tissue health and maintenance of the NobelActive Internal and External implants and to make comparisons with...
Detailed Description
The purpose of this study is to determine safety and efficacy parameters for the NobelActive Internal and External implants and to make comparisons with the NobelReplace Tapered Groovy implant placed ...
Eligibility Criteria
Inclusion
- The subject should be in need of an implant supported fixed restoration
- The subjects should have sufficient bone volume and density i.e. an osseous architecture in the planned implant placement region sufficient to receive implants with a diameter of 3.5 mm and a length of at least 10 mm.
- The subject as well as the implant sites should fulfill criteria for immediate functional tem-porization within 24 h.
- The implant sites should be healed and free from infection.
Exclusion
- Alcohol or drug abuse as noted in patient records or in patient history.
- Health conditions, which do not permit the surgical procedure.
- Reason to believe that the treatment might have a negative effect on the subject's total situation (psychiatric problems), as noted in patient records or in patient history.
- The subject is not able to give her/his informed consent to participate.
- The need of bone augmentation before implant installation to obtain a prosthetically correct implantation transversally. However, a minor augmentation procedure to cover exposed threads or interproximal / buccal grafting due to deficient sites is not an exclusion criteria.
- Any disorders in the planned implant area such as previous tumors, chronic bone disease, or previous irradiation.
- Uncontrolled diabetics will be excluded.
- Severe bruxism or other destructive habits.
- Immediate insertion (e.g. placement of the implant immediately after extraction) consti-tutes an exclusion criterion.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT01397617
Start Date
April 1 2006
End Date
May 1 2013
Last Update
April 22 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.